Wikidata

(Q44333462)

English

Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation

scientific article

In more languages

Statements

title
Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12610022
retrieved
2 December 2017
author name string
William H Herman
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12610022
retrieved
2 December 2017
Shahnaz Shahinfar
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12610022
retrieved
2 December 2017
George W Carides
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
12610022
retrieved
2 December 2017
Erik J Dasbach
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12610022
retrieved
2 December 2017
William C Gerth
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
12610022
retrieved
2 December 2017
Charles M Alexander
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
12610022
retrieved
2 December 2017
John R Cook
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
12610022
retrieved
2 December 2017
William F Keane
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
12610022
retrieved
2 December 2017
Barry M Brenner
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
12610022
retrieved
2 December 2017
publication date
1 March 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
12610022
retrieved
2 December 2017
page(s)
683-687
1 reference
stated in
Europe PubMed Central
PubMed ID
12610022
retrieved
2 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44333462&oldid=2109495499"